US Patent Issued to UNIVERSITY OF SHARJAH on June 24 for "Formulation for atropine sulfate rapidly-disintegrating sublingual tablets" (Emirati Inventors)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,337,063, issued on June 24, was assigned to UNIVERSITY OF SHARJAH (Sharjah, United Arab Emirates).

"Formulation for atropine sulfate rapidly-disintegrating sublingual tablets" was invented by Mutasem Rawas-Qalaji (Sharjah, United Arab Emirates) and Rawan S. Bafail (Sharjah, United Arab Emirates).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides atropine sulfate (AS) rapidly-disintegrating sublingual tablets (RDSTs) of improved formulation in a sublingual dosage form and methods for therapeutic use of the AS RDSTs for treatment of organophosphate (OP) exposure and acute toxicity. The AS RDSTs provide an alternative easy-to-use dosage f...